Danish Bacille Calmette-Guérin Vaccine-Induced Disease in Human Immunodeficiency Virus-Infected Children

Clinical Infectious Diseases

Volumn 37, Issue 9, 2003, Pages 1226-1233

  Hesseling, A C ^a,d   Schaaf, H S ^a   Hanekom, W A ^c   Beyers, N ^a   Cotton, M F ^a   Gie, R P ^a   Marais, B J ^a   Van Helden, P ^b   Warren, R M ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DANISH BCG VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; AXILLARY LYMPH NODE; AXILLARY LYMPHADENITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DANISH MYCOBACTERIUM BOVIS BCG STRAIN; DRUG INDUCED DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG DISEASE; LUNG TUBERCULOSIS; LYMPHADENITIS; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TOKYO MYCOBACTERIUM BOVIS BCG STRAIN;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BCG VACCINE; CHILD; HIV INFECTIONS; HUMANS; INFANT; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0242490751     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/378298     Document Type: Article

References (36)

1. Fourie PB. BCG vaccination and the EPI. S Afr Med J 1987; 72:323-6.
2. Fine PEM, Carneiro-IAM, Milstien JB, Clements CJ. Issues relating to the use of BCG immunization programmes - a discussion document. World Health Organization (WHO) document no. WHO/V&B/99.23. Geneva: WHO, 1999.
3. Milstien JB, Gibson JJ. Quality control of BCG by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ 1990; 68:93-108.
4. Lotte A, Wasz-Hockert O, Poisson N, et al. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis 1988; 63:47-59.
5. Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis 1997; 24:1139-46.
6. World Health Organization. Expanded Programme on Immunization: Global Advisory Group. Wkly Epidemiol Rec 1990; 65:5-11.
7. Global Programme for Vaccines and Immunization Policy. Geneva: World Health Organization, 1996.
8. Lumb R, Shaw D. Mycobacterium bovis (BCG) vaccination: progressive disease in a patient asymptomatically infected with the human immunodeficiency virus. Med J Aust 1992; 156:286-7.
9. Smith E, Thybo S, Bennedsen J. Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand J Infect Dis 1992; 24:109-10.
10. Nousbaum JB, Garre M, Boles JM, Garo B, Larzul JJ. Deux mainfestationa inhabituelles d'une infection par le virus LAV-HTLV III: BCG-ite et varicelle pulmonaire. Rev Pneumol Clin 1986; 42:310-1.
11. Blondon H, Guez T, Paul G, Trufot-Pernot CH, Sicard D. Adenite a BCG 6 ans apres la vaccination au cours d'un SIDA. Presse Med 1991; 20:1091.
12. Weltman AC, Rose DN. The safety of Bacille Calmette-Guerin vaccination in HIV infection and AIDS. AIDS 1993; 7:149-57.
13. Armbruster C, Junker W, Vetter N, Jaksch G. Disseminated bacille Calmette-Guerin infection in an AIDS patient 30 years after BCG vaccination. J Infect Dis 1990; 162:1216.
14. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-95.
15. Talbot EA, Williams DL, Frothingham R. PCR identification of Mycobacterium bovis BCG. J Clin Microbiol 1997; 35:566-9.
16. Parsons LM, Brosch R, Cole ST, et al. Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol 2002; 40:2339-45.
17. Beyers N, Michaelis I, Gie RP, et al. Transmission of tuberculosis to children in a high incidence area. Int J Tuberc Lung Dis 2001; 5(Suppl 1):S185.
18. South African Department of Health. Western Cape: the provincial and district HIV antenatal survey. Cape Town, South Africa: Department of Health, Western Cape, 2001.
19. Brosch R, Gordon SV, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002; 99:3684-9.
20. Kamerbeek J, van Embden J, Schouls L, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35:907-14.
21. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43(RR-12):1-10.
22. Jeena PM, Chagan MK, Topley J, Coovadia HM. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa. Bull World Health Organ 2001; 79:337-43.
23. Van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341:1174-9.
24. French MAH, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992; 6:1293-7.
25. Berning SE, Huitt GA, Iseman MD, Peloquin CA. Malabsorption of antituberculous medications by a patient with AIDS. N Engl J Med 1992; 327:1817-8.
26. Small PM, Schecter G, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced immunodeficiency virus infection. N Engl J Med 1991; 324:289-94.
27. Sicevic S. Generalized BCG tuberculosis with fatal course in two sisters. Acta Paediatr Scand 1972; 61:178-84.
28. Hengster P, Solder B, Fille M, Menardi G. Surgical treatment of bacillus Calmette Guerin lymphadenitis. World J Surg 1997; 21:520-3.
29. Nicol M, Eley B, Kibel M, Hussey G. Intradermal BCG vaccination-adverse reactions and their management. S Afr Med J 2002; 92:39-42.
30. Bologna R, Sarkis C, Trinidad P, Casimir L, Lovadina L, Mecikovsky D. Disseminated BCG infection in children with HIV-infection [abstract 1308]. In: Program and abstracts of the 13th International AIDS Conference (Durban, South Africa). Stockholm: International AIDS Society, 2000.
31. Gutman LT, Moye J, Zimmer B, Tian C. Tuberculosis in human immunodeficiency virus-exposed or -infected United States children. Pediatr Infect Dis J 1994; 13:963-8.
32. Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 2003; 81:61-70.
33. O'Brien KL, Ruff AJ, Louis MA, et al. Bacillus Calmette-Guerin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics 1995; 95:414-8.
34. Thaithumyanon P, Thisyakorn U, Punnahitananda S, Praissuwanna P, Ruxrungtham K. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-infected mothers. Southeast Asian J Trop Med Public Health 2000; 31:482-6.
35. Colebunders RL, Izaley L, Musampu M, Pauwels P, Francis H, Ryder R. BCG vaccination abscesses are unrelated to HIV infection. JAMA 1988; 259:352.
36. Wright P. Research opportunities to determine the safety of BCG vaccine in areas with high HIV prevalence. World Health Organization (WHO) document no. EPI/18/446/8. Geneva: WHO, 1987.